 |
市場調查報告書
商品編碼
1402081
全球過敏性肺炎市場研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢與預測Global Hypersensitivity Pneumonitis Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
||||||
全球過敏性肺炎市場需求預計將從 2022 年的 956.5 萬美元達到 2030 年近 1,441.42 萬美元的市場規模，2023-2030 年研究期間CAGR為 5.26%。
過敏性肺炎 (HP) 或外源性過敏性肺泡炎是一種罕見的肺部疾病，由反覆接觸各種有機物質或過敏原引發。當易感人群吸入這些物質時，他們的免疫系統會產生過度的免疫反應，導致肺部發炎。
市場動態
認知的提高和診斷能力的提高可以更好地識別和報告過敏性肺炎病例，從而推動對診斷測試和管理策略的需求。農業和木工等行業的職業暴露，以及黴菌或鳥糞等環境因素，大大促進了這種疾病的流行。包括影像技術和肺功能測試在內的診斷技術的進步在過敏性肺炎的準確和早期診斷中發揮關鍵作用，從而促進了對診斷工具的需求。專注於了解 HP 機制和風險因素的研究措施帶來了新的診斷方法和治療方法，進一步擴大了市場。全球不斷成長的醫療保健支出使惠普管理層能夠改善患者護理並獲得醫療保健服務。有關職業安全和環境健康的支持性政府政策、法規和指南有助於創造有利於解決過敏性肺炎的環境。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球過敏性肺炎市場的各個細分市場進行了包容性評估。過敏性肺炎產業的成長和趨勢為本研究提供了整體方法。
區域分析
本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲過敏性肺炎市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。過敏性肺炎市場的主要參與者包括強生服務公司、霍夫曼拉羅氏有限公司、勃林格殷格翰國際有限公司、阿斯特捷利康公司、葛蘭素史克公司、輝瑞公司、賽諾菲公司、梯瓦製藥工業有限公司。 、諾華國際公司、默克公司等。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。
如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
目錄
第1章：前言
- 報告說明
- 客觀的
- 目標受眾
- 獨特的銷售主張 (USP) 和產品
- 研究範圍
- 研究方法論
- 市場研究過程
- 市場研究方法論
第 2 章：執行摘要
- 市場亮點
- 全球市場概況
第 3 章：過敏性肺炎 - 產業分析
- 簡介 - 市場動態
- 市場促進因素
- 市場限制
- 機會
- 產業動態
- 波特五力分析
- 市場吸引力分析
- 按曝光來源進行的市場吸引力分析
- 按類型分類的市場吸引力分析
- 市場吸引力診斷分析
- 市場吸引力分析：按地區
第 4 章：價值鏈分析
- 價值鏈分析
- 原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
- 潛在買家名單
- 行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢
第 5 章：全球過敏性肺炎市場分析：依暴露來源分類
- 按接觸源分類的概述
- 歷史和預測數據
- 按暴露來源分析
- 職業曝露
- 環境過敏原
- 藥物引起的暴露
- 其他
第 6 章：全球過敏性肺炎市場分析：按類型
- 按類型概述
- 歷史和預測數據
- 按類型分析
- 慢性過敏性肺炎
- 急性過敏性肺炎
第 7 章：全球過敏性肺炎市場分析：透過診斷
- 診斷概述
- 歷史和預測數據
- 診斷分析
- 肺功能測試
- 影像學檢查
- 活體組織切片
- 其他
第 8 章：全球過敏性肺炎市場分析：依地理位置
- 區域展望
- 介紹
- 北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
- 歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
- 亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
- 拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
- 中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析
第 9 章：過敏性肺炎公司的競爭格局
- 過敏性肺炎市場競爭
- 夥伴關係/協作/協議
- 併購
- 新產品發布
- 其他發展
第 10 章：公司簡介
- 公司股份分析
- 市場集中度
- Johnson & Johnson Services Inc.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- F.Hoffmann-La Roche Ltd.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Boehringer Ingelheim International GmbH
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- AstraZeneca Plc.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- GlaxoSmithKline plc.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Pfizer Inc.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Sanofi SA
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Teva Pharmaceutical Industries Ltd.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Novartis International AG
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Merck KGaA
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- 其他
- 公司簡介
- 公司收入
- 產品
- 最近的發展
注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內
The global demand for Hypersensitivity Pneumonitis Market is presumed to reach the market size of nearly USD 1441.42 MN by 2030 from USD 956.5 MN in 2022 with a CAGR of 5.26% under the study period 2023 - 2030.
Hypersensitivity pneumonitis (HP), or extrinsic allergic alveolitis, is a rare lung condition triggered by repeated exposure to various organic substances or allergens. When susceptible individuals inhale these substances, their immune system mounts an exaggerated immune response, causing inflammation in the lungs.
MARKET DYNAMICS
Increased awareness and improved diagnostic capabilities lead to better identification and reporting of hypersensitivity pneumonitis cases, driving demand for diagnostic tests and management strategies. Occupational exposures in industries like agriculture and woodworking, along with environmental factors such as mold or bird droppings, contribute significantly to the condition's prevalence. Advancements in diagnostic technologies, including imaging techniques and pulmonary function tests, play a pivotal role in accurate and early hypersensitivity pneumonitis diagnosis, fostering demand for diagnostic tools. Research initiatives focusing on understanding HP's mechanisms and risk factors lead to novel diagnostic methods and treatments, further expanding the market. Rising healthcare expenditure globally enables improved patient care and access to healthcare services for HP management. Supportive government policies, regulations, and guidelines pertaining to occupational safety and environmental health contribute to creating an environment conducive to addressing hypersensitivity pneumonitis.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of hypersensitivity pneumonitis. The growth and trends of hypersensitivity pneumonitis industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the hypersensitivity pneumonitis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Source Of Exposure
- Occupational Exposure
- Environmental Allergens
- Drug-Induced Exposure
- Others
By Type
- Chronic Hypersensitivity Pneumonitis
- Acute Hypersensitivity Pneumonitis
By Diagnosis
- Pulmonary Function Tests
- Imaging Tests
- Biopsy
- Others
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the Hypersensitivity Pneumonitis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Hypersensitivity Pneumonitis market include Johnson & Johnson Services Inc., F.Hoffmann-La Roche Ltd., Boehringer Ingelheim International GmbH, AstraZeneca Plc., GlaxoSmithKline plc., Pfizer Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Novartis International AG, Merck KGaA, and others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . HYPERSENSITIVITY PNEUMONITIS - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Source of Exposure
- 3.7.2 Market Attractiveness Analysis By Type
- 3.7.3 Market Attractiveness Analysis By Diagnosis
- 3.7.4 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . GLOBAL HYPERSENSITIVITY PNEUMONITIS MARKET ANALYSIS BY SOURCE OF EXPOSURE
- 5.1 Overview by Source of Exposure
- 5.2 Historical and Forecast Data
- 5.3 Analysis by Source of Exposure
- 5.4 Occupational Exposure Historic and Forecast Sales by Regions
- 5.5 Environmental Allergens Historic and Forecast Sales by Regions
- 5.6 Drug-Induced Exposure Historic and Forecast Sales by Regions
- 5.7 Others Historic and Forecast Sales by Regions
6 . GLOBAL HYPERSENSITIVITY PNEUMONITIS MARKET ANALYSIS BY TYPE
- 6.1 Overview by Type
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Type
- 6.4 Chronic Hypersensitivity Pneumonitis Historic and Forecast Sales by Regions
- 6.5 Acute Hypersensitivity Pneumonitis Historic and Forecast Sales by Regions
7 . GLOBAL HYPERSENSITIVITY PNEUMONITIS MARKET ANALYSIS BY DIAGNOSIS
- 7.1 Overview by Diagnosis
- 7.2 Historical and Forecast Data
- 7.3 Analysis by Diagnosis
- 7.4 Pulmonary Function Tests Historic and Forecast Sales by Regions
- 7.5 Imaging Tests Historic and Forecast Sales by Regions
- 7.6 Biopsy Historic and Forecast Sales by Regions
- 7.7 Others Historic and Forecast Sales by Regions
8 . GLOBAL HYPERSENSITIVITY PNEUMONITIS MARKET ANALYSIS BY GEOGRAPHY
- 8.1. Regional Outlook
- 8.2. Introduction
- 8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
- 8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
- 8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
- 8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
- 8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis
9 . COMPETITIVE LANDSCAPE OF THE HYPERSENSITIVITY PNEUMONITIS COMPANIES
- 9.1. Hypersensitivity Pneumonitis Market Competition
- 9.2. Partnership/Collaboration/Agreement
- 9.3. Merger And Acquisitions
- 9.4. New Product Launch
- 9.5. Other Developments
10 . COMPANY PROFILES OF HYPERSENSITIVITY PNEUMONITIS INDUSTRY
- 10.1. Company Share Analysis
- 10.2. Market Concentration Rate
- 10.3. Johnson & Johnson Services Inc.
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
- 10.4. F.Hoffmann-La Roche Ltd.
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
- 10.5. Boehringer Ingelheim International GmbH
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
- 10.6. AstraZeneca Plc.
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
- 10.7. GlaxoSmithKline plc.
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
- 10.8. Pfizer Inc.
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
- 10.9. Sanofi S.A.
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
- 10.10. Teva Pharmaceutical Industries Ltd.
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
- 10.11. Novartis International AG
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
- 10.12. Merck KGaA
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
- 10.13. Others
- 10.13.1. Company Overview
- 10.13.2. Company Revenue
- 10.13.3. Products
- 10.13.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- Analysis by Source of Exposure (USD MN)
- Occupational Exposure Market Sales by Geography (USD MN)
- Environmental Allergens Market Sales by Geography (USD MN)
- Drug-Induced Exposure Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Analysis Market by Type (USD MN)
- Chronic Hypersensitivity Pneumonitis Market Sales by Geography (USD MN)
- Acute Hypersensitivity Pneumonitis Market Sales by Geography (USD MN)
- Analysis by Diagnosis (USD MN)
- Pulmonary Function Tests Market Sales by Geography (USD MN)
- Imaging Tests Market Sales by Geography (USD MN)
- Biopsy Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Hypersensitivity Pneumonitis Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- South East Asia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Hypersensitivity Pneumonitis Report
- Market Research Process
- Market Research Methodology
- Global Hypersensitivity Pneumonitis Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Source of Exposure
- Market Attractiveness Analysis by Type
- Market Attractiveness Analysis by Diagnosis
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Source of Exposure (USD MN)
- Occupational Exposure Market Sales by Geography (USD MN)
- Environmental Allergens Market Sales by Geography (USD MN)
- Drug-Induced Exposure Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market Analysis by Type (USD MN)
- Chronic Hypersensitivity Pneumonitis Market Sales by Geography (USD MN)
- Acute Hypersensitivity Pneumonitis Market Sales by Geography (USD MN)
- Global Market Analysis by Diagnosis (USD MN)
- Pulmonary Function Tests Market Sales by Geography (USD MN)
- Imaging Tests Market Sales by Geography (USD MN)
- Biopsy Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market Sales (USD MN)
- North America Market Sales (USD MN)
- Europe Market Sales (USD MN)
- Asia Pacific Market Sales (USD MN)
- Latin America Market Sales (USD MN)
- Middle East & Africa Market Sales (USD MN)
- Recent Development in Industry
- Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
